Literature DB >> 26007637

A recurrent KCNQ2 pore mutation causing early onset epileptic encephalopathy has a moderate effect on M current but alters subcellular localization of Kv7 channels.

Affef Abidi1, Jérôme J Devaux2, Florence Molinari3, Gisèle Alcaraz1, François-Xavier Michon3, Julie Sutera-Sardo4, Hélène Becq3, Caroline Lacoste5, Cécilia Altuzarra6, Alexandra Afenjar7, Cyril Mignot8, Diane Doummar9, Bertrand Isidor10, Sylvie N Guyen11, Estelle Colin12, Sabine De La Vaissière13, Damien Haye14, Adeline Trauffler15, Catherine Badens5, Fabienne Prieur16, Gaetan Lesca17, Laurent Villard1, Mathieu Milh18, Laurent Aniksztejn19.   

Abstract

Mutations in the KCNQ2 gene encoding the voltage-dependent potassium M channel Kv7.2 subunit cause either benign epilepsy or early onset epileptic encephalopathy (EOEE). It has been proposed that the disease severity rests on the inhibitory impact of mutations on M current density. Here, we have analyzed the phenotype of 7 patients carrying the p.A294V mutation located on the S6 segment of the Kv7.2 pore domain (Kv7.2(A294V)). We investigated the functional and subcellular consequences of this mutation and compared it to another mutation (Kv7.2(A294G)) associated with a benign epilepsy and affecting the same residue. We report that all the patients carrying the p.A294V mutation presented the clinical and EEG characteristics of EOEE. In CHO cells, the total expression of Kv7.2(A294V) alone, assessed by western blotting, was only 20% compared to wild-type. No measurable current was recorded in CHO cells expressing Kv7.2(A294V) channel alone. Although the total Kv7.2(A294V) expression was rescued to wild-type levels in cells co-expressing the Kv7.3 subunit, the global current density was still reduced by 83% compared to wild-type heteromeric channel. In a configuration mimicking the patients' heterozygous genotype i.e., Kv7.2(A294V)/Kv7.2/Kv7.3, the global current density was reduced by 30%. In contrast to Kv7.2(A294V), the current density of homomeric Kv7.2(A294G) was not significantly changed compared to wild-type Kv7.2. However, the current density of Kv7.2(A294G)/Kv7.2/Kv7.3 and Kv7.2(A294G)/Kv7.3 channels were reduced by 30% and 50% respectively, compared to wild-type Kv7.2/Kv7.3. In neurons, the p.A294V mutation induced a mislocalization of heteromeric mutant channels to the somato-dendritic compartment, while the p.A294G mutation did not affect the localization of the heteromeric channels to the axon initial segment. We conclude that this position is a hotspot of mutation that can give rise to a severe or a benign epilepsy. The p.A294V mutation does not exert a dominant-negative effect on wild-type subunits but alters the preferential axonal targeting of heteromeric Kv7 channels. Our data suggest that the disease severity is not necessarily a consequence of a strong inhibition of M current and that additional mechanisms such as abnormal subcellular distribution of Kv7 channels could be determinant.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Early epileptic encephalopathy; Kv7 channels; M-current; Subcellular channel expression; p.A294G mutation; p.A294V mutation

Mesh:

Substances:

Year:  2015        PMID: 26007637     DOI: 10.1016/j.nbd.2015.04.017

Source DB:  PubMed          Journal:  Neurobiol Dis        ISSN: 0969-9961            Impact factor:   5.996


  22 in total

Review 1.  Modulation of Kv7 channels and excitability in the brain.

Authors:  Derek L Greene; Naoto Hoshi
Journal:  Cell Mol Life Sci       Date:  2016-09-19       Impact factor: 9.261

Review 2.  Ion Channel Genes and Epilepsy: Functional Alteration, Pathogenic Potential, and Mechanism of Epilepsy.

Authors:  Feng Wei; Li-Min Yan; Tao Su; Na He; Zhi-Jian Lin; Jie Wang; Yi-Wu Shi; Yong-Hong Yi; Wei-Ping Liao
Journal:  Neurosci Bull       Date:  2017-05-09       Impact factor: 5.203

3.  Infantile spasms and encephalopathy without preceding neonatal seizures caused by KCNQ2 R198Q, a gain-of-function variant.

Authors:  John J Millichap; Francesco Miceli; Michela De Maria; Cynthia Keator; Nishtha Joshi; Baouyen Tran; Maria Virginia Soldovieri; Paolo Ambrosino; Vandana Shashi; Mohamad A Mikati; Edward C Cooper; Maurizio Taglialatela
Journal:  Epilepsia       Date:  2016-11-09       Impact factor: 5.864

4.  Reduced axonal surface expression and phosphoinositide sensitivity in Kv7 channels disrupts their function to inhibit neuronal excitability in Kcnq2 epileptic encephalopathy.

Authors:  Eung Chang Kim; Jiaren Zhang; Weilun Pang; Shuwei Wang; Kwan Young Lee; John P Cavaretta; Jennifer Walters; Erik Procko; Nien-Pei Tsai; Hee Jung Chung
Journal:  Neurobiol Dis       Date:  2018-07-06       Impact factor: 5.996

5.  Retigabine, a Kv7.2/Kv7.3-Channel Opener, Attenuates Drug-Induced Seizures in Knock-In Mice Harboring Kcnq2 Mutations.

Authors:  Yukiko Ihara; Yuko Tomonoh; Masanobu Deshimaru; Bo Zhang; Taku Uchida; Atsushi Ishii; Shinichi Hirose
Journal:  PLoS One       Date:  2016-02-24       Impact factor: 3.240

6.  Early-onset epileptic encephalopathy caused by a reduced sensitivity of Kv7.2 potassium channels to phosphatidylinositol 4,5-bisphosphate.

Authors:  Maria Virginia Soldovieri; Paolo Ambrosino; Ilaria Mosca; Michela De Maria; Edoardo Moretto; Francesco Miceli; Alessandro Alaimo; Nunzio Iraci; Laura Manocchio; Alessandro Medoro; Maria Passafaro; Maurizio Taglialatela
Journal:  Sci Rep       Date:  2016-12-01       Impact factor: 4.379

7.  De Novo KCNQ2 Mutation in One Case of Epilepsy of Infancy With Migrating Focal Seizures That Evolved to Infantile Spasms.

Authors:  Haolin Duan; Jing Peng; Miriam Kessi; Fei Yin
Journal:  Child Neurol Open       Date:  2018-04-11

8.  Novel Dominant KCNQ2 Exon 7 Partial In-Frame Duplication in a Complex Epileptic and Neurodevelopmental Delay Syndrome.

Authors:  Pedro A Lazo; Juan L García; Paulino Gómez-Puertas; Íñigo Marcos-Alcalde; Cesar Arjona; Alvaro Villarroel; Rogelio González-Sarmiento; Carmen Fons
Journal:  Int J Mol Sci       Date:  2020-06-23       Impact factor: 5.923

9.  A novel homozygous KCNQ3 loss-of-function variant causes non-syndromic intellectual disability and neonatal-onset pharmacodependent epilepsy.

Authors:  Anna Lauritano; Sebastien Moutton; Elena Longobardi; Frédéric Tran Mau-Them; Giusy Laudati; Piera Nappi; Maria Virginia Soldovieri; Paolo Ambrosino; Mauro Cataldi; Thibaud Jouan; Daphné Lehalle; Hélène Maurey; Christophe Philippe; Francesco Miceli; Antonio Vitobello; Maurizio Taglialatela
Journal:  Epilepsia Open       Date:  2019-08-11

10.  Retigabine holds KV7 channels open and stabilizes the resting potential.

Authors:  Aaron Corbin-Leftwich; Sayeed M Mossadeq; Junghoon Ha; Iwona Ruchala; Audrey Han Ngoc Le; Carlos A Villalba-Galea
Journal:  J Gen Physiol       Date:  2016-02-15       Impact factor: 4.086

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.